UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 28, 2021 5:00 P.M.
Form: S-3
CIK: 0001534248
Company Name: Chemomab Therapeutics Ltd.
File Number: 333-255249